1[1]Jancloes M,Martin JD.Attacking poverty and improving health:a report on the WHO/State of Maryland International Health Congress,Baltimore,September 1997[J].Trop Med Int Health,1998,3(4):333-336.
2[2]Murray CJ,Lopez AD.Evidence-based health policylessons from the Global Burden of Disease Study[J].Science,1996,274(5288):740-743.
3[3]Calverley P,Pauwels Dagger R,Lofdahl CG,et al.Relationship between respiratory symptoms and medical treatment in exacerbations of COPD[J].Eur Respir J,2005,26(3):406-413.
4[4]Connett JE,Murry RP,Buist AS,et al.Changes in smoking status affect women more than men:results of the Lung Health Study[J].Am J Epidemiol,2003,157(11):973-979.
5[5]Seemungal TA,Donaldson GC,Bhowmik A,et al.Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2000,161(5):1608-1613.
6[6]Kanner RE,Anthonisen NR,Connett JE,et al.Lower respiratory illnesses promote FEV (1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease:results from the lung health study[J].Am J Respir Crit Care Med,2001,164(3):358-364.
7[7]MacNee W.Acute exacerbations of COPD[J].Swiss Med Wkly,2003,133(17-18):247-257.
8[8]McCrory DC,Brown C,Gelfand SE,et al.Management of acute exacerbations of COPD:a summary and appraisal of published evidence[J].Chest,2001,119(4):1190-1209.
9[9]Kanner RE,Anthonisen NR,Connett JE.Lower respiratory illnesses promote FEV (1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease:results from the lung health study[J].Am J Respir Crit Care Med,2001,164(3):358-364.
10[10]Anthonisen NR,Manfreda J,Warren CP,et al.Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease[J].Ann Intern Med,1987,106(2):196-204.
